...
首页> 外文期刊>Blood purification >Itch and Ache on Dialysis: New Approaches to Manage Uremic Pruritus and Restless Legs
【24h】

Itch and Ache on Dialysis: New Approaches to Manage Uremic Pruritus and Restless Legs

机译:透析的瘙痒和疼痛:管理尿毒瘙痒和不安腿的新方法

获取原文
获取原文并翻译 | 示例
           

摘要

Background: Uremic pruritus (UP) and restless legs syndrome (RLS) are highly prevalent complaints among patients with end-stage renal disease (ESRD) undergoing chronic dialysis. These chronic troublesome symptoms lead to a significant decrease in quality of life (QOL) and increase in mortality rate. Despite their distressing characteristics, these symptoms usually remain under-recognized by healthcare providers. Therefore, careful history intake, and stepwise treatment are essential. Numerous pharmacological and non-pharmacological treatments have been demonstrated to help in controlling these 2 conditions. Summary: In this review, we discuss the latest findings regarding UP and RLS among ESRD patients on maintenance dialysis. We also examine different treatment options in this group of patients. The majority of these patients do not have the opportunity to receive a kidney transplant and need other treatments for these burdensome symptoms in order to improve their QOL and prognosis. Key Messages: UP and RLS are common but underdiagnosed conditions in ESRD patients on maintenance dialysis that are related to a decline in patients' QOL and poor prognosis. The pathophysiology of these conditions remains not well understood. Therefore, controversies still exist on treatment options. Treating these conditions provides an opportunity to improve the health-related QOL and outcomes of dialysis patients.
机译:背景:尿毒症瘙痒(UP)和焦躁的腿综合征(RLS)是患有慢性透析的末期肾病(ESRD)患者的患者高度普遍的抱怨。这些慢性麻烦的症状导致生活质量(QOL)的显着降低,并增加死亡率。尽管其特征令人痛苦,但这些症状通常仍然受到医疗保健提供者的认可。因此,仔细的历史摄入,逐步治疗至关重要。已经证明了许多药理学和非药理学处理有助于控制这两个条件。摘要:在本报告中,我们讨论了对维持透析的ESRD患者的上涨和RLS的最新结果。我们还在这组患者中检查了不同的治疗方案。这些患者中的大多数人没有机会接受肾移植,需要其他治疗,以便改善他们的QoL和预后。关键消息:UP和RLS是常见的,但在ESRD患者的维持透析患者中​​有常见的病症,这些病症与患者QoL的下降和预后差有关。这些条件的病理生理学仍未得到很好的理解。因此,治疗方案仍存在争议。处理这些条件为改善与透析患者的健康相关QoL和结果提供了机会。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号